Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (80%) |
| Double-patenting only | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WALKER, MARNITIA TRARESE | 1 | — | — |
| HOFFMAN, SUSAN COE | 1 | 54.1% | +25.6% |
| BATES, KEENAN ALEXANDER | 1 | 46.3% | +70.8% |
| MELLER, MICHAEL V | 1 | 46.1% | +28.6% |
| UNDERDAHL, THANE E | 1 | 59.0% | +50.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18220043 | USE OF EXTRACT IN MANUFACTURING A PHARMACEUTICAL OR NON-PHARMACEUTICAL COMPOSITION FOR ENHANCING THE ACTIVITY OF MITOCHONDRIA | HOFFMAN, SUSAN COE | 217d overdue |
| 17982805 | PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR REPAIRING DAMAGED LIVER, TREATING DISEASE ASSOCIATED WITH DAMAGED LIVER AND IMPROVING FUNCTIONS OF LIVER | BATES, KEENAN ALEXANDER | 2d overdue |
| 17912394 | USE OF MITOCHONDRIAL EXTRACT TO TREAT AND/OR PREVENT KIDNEY INJURY-RELATED DISEASE | UNDERDAHL, THANE E | 40d |
| 17948007 | COMPOSITION COMPRISING MITOCHONDRIA AND USE THEREOF FOR REPAIRING CARTILAGE DAMAGE OR IMPROVING OSTEOARTHRITIS | MELLER, MICHAEL V | — |
| Art Unit | Apps |
|---|---|
| 1655 | 3 |
| 1631 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18436561 | METHOD FOR ENHANCING BIOLOGICAL ENERGY WITH EXTRACT | WALKER, MARNITIA TRARESE | 1655 | §103 | Final Rejection | 83d | Pending | Feb 08, 2024 |
| 18220043 | USE OF EXTRACT IN MANUFACTURING A PHARMACEUTICAL OR NON-PHARMACEUTICAL COMPOSITION FOR ENHANCING THE ACTIVITY OF MITOCHONDRIA | HOFFMAN, SUSAN COE | 1655 | §103 | Non-Final OA | 217d overdue | Pending | Jul 10, 2023 |
| 17982805 | PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR REPAIRING DAMAGED LIVER, TREATING DISEASE ASSOCIATED WITH DAMAGED LIVER AND IMPROVING FUNCTIONS OF LIVER | BATES, KEENAN ALEXANDER | 1631 | §103 | Final Rejection | 2d overdue | Pending | Nov 08, 2022 |
| 17948007 | COMPOSITION COMPRISING MITOCHONDRIA AND USE THEREOF FOR REPAIRING CARTILAGE DAMAGE OR IMPROVING OSTEOARTHRITIS | MELLER, MICHAEL V | 1655 | DP | Final Rejection | — | Pending | Sep 19, 2022 |
| 17912394 | USE OF MITOCHONDRIAL EXTRACT TO TREAT AND/OR PREVENT KIDNEY INJURY-RELATED DISEASE | UNDERDAHL, THANE E | 1699 | §103 | Non-Final OA | 40d | Pending | Sep 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial